Showing results (21-30 of 52) with videos related to
Sort By:
Pageof 6
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|February 27, 2023
Polymicrobial infections and antibiotic treatment patterns for cystic fibrosis pulmonary exacerbationsAnna V Faino, Lucas R Hoffman, Ronald L Gibson, et al.Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|March 13, 2024
Creation of a CF-specific antibiotic spectrum index (ASI) as an antimicrobial stewardship initiativeJonathan D Cogen, Sonya L Heltshe, Adam W Brothers, et al.Annals of the American Thoracic Society|August 31, 2022
Systemic Corticosteroids in the Management of Pediatric Cystic Fibrosis Pulmonary ExacerbationsChelsea S Davis, Anna V Faino, Frankline Onchiri, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 8, 2021
Association Between Number of Intravenous Antipseudomonal Antibiotics and Clinical Outcomes of Pediatric Cystic Fibrosis Pulmonary ExacerbationsJonathan D Cogen, Anna V Faino, Frankline Onchiri, et al.American Journal of Respiratory and Critical Care Medicine|October 30, 2019
Pulmonary Outcomes Associated with Long-Term Azithromycin Therapy in Cystic FibrosisDave P Nichols, Katherine Odem-Davis, Jonathan D Cogen, et al.Annals of the American Thoracic Society|March 15, 2022
Clinical Outcomes of Antipseudomonal versus Other Antibiotics among Children with Cystic Fibrosis without <i>Pseudomonas aeruginosa</i>Jonathan D Cogen, Anna V Faino, Frankline Onchiri, et al.Annals of the American Thoracic Society|August 19, 2020
Effect of Concomitant Azithromycin and Tobramycin Use on Cystic Fibrosis Pulmonary Exacerbation TreatmentJonathan D Cogen, Anna V Faino, Frankline Onchiri, et al.Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|August 10, 2023
The impact of elexacaftor/tezacaftor/ivacaftor on fat-soluble vitamin levels in people with cystic fibrosisGeorgene E Hergenroeder, Anna Faino, Gracia Bridges, et al.Annals of the American Thoracic Society|June 16, 2023
Antibiotic Regimen Changes during Cystic Fibrosis Pediatric Pulmonary Exacerbation TreatmentJonathan D Cogen, Don B Sanders, James E Slaven, et al.Annals of the American Thoracic Society|March 7, 2019
Oral Azithromycin Use and the Recovery of Lung Function from Pulmonary Exacerbations Treated with Intravenous Tobramycin or Colistimethate in Adults with Cystic FibrosisRanjani Somayaji, Renee Russell, Jonathan D Cogen, et al.Pageof 6